|
Name |
Bicyclo[2.2.2]octane-1-carboxylic acid
|
Molecular Formula | C9H14O2 | |
IUPAC Name* |
bicyclo[2.2.2]octane-1-carboxylic acid
|
|
SMILES |
C1CC2(CCC1CC2)C(=O)O
|
|
InChI |
InChI=1S/C9H14O2/c10-8(11)9-4-1-7(2-5-9)3-6-9/h7H,1-6H2,(H,10,11)
|
|
InChIKey |
PUNFICOCZAPAJV-UHFFFAOYSA-N
|
|
Synonyms |
Bicyclo[2.2.2]octane-1-carboxylic acid; 699-55-8; Bicyclo(2.2.2)octane-1-carboxylic acid; UWD2HS8EZZ; MFCD00218755; NSC-143953; bicyclo[2.2.2]octane-4-carboxylic acid; UNII-UWD2HS8EZZ; SCHEMBL587339; BDBM36205; DTXSID40220184; ZINC1727617; bicyclo[2.2.2]octane-1-carboxylic; NSC143953; AKOS016001404; CS-W008717; GS-6029; NSC 143953; SB12138; Bicyclo[2.2.2]octane-1-carboxylicacid; SY143052; Bicyclo[2.2.2]octane-1-carboxylic acicd; FT-0699418; EN300-106638; Bicyclo[2.2.2]octane-l-carboxylic acid (222); A866710; Z1262510557
|
|
CAS | 699-55-8 | |
PubChem CID | 136534 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 154.21 | ALogp: | 2.1 |
HBD: | 1 | HBA: | 2 |
Rotatable Bonds: | 1 | Lipinski's rule of five: | Accepted |
Polar Surface Area: | 37.3 | Aromatic Rings: | 3 |
Heavy Atoms: | 11 | QED Weighted: | 0.63 |
Caco-2 Permeability: | -4.846 | MDCK Permeability: | 0.00001180 |
Pgp-inhibitor: | 0.01 | Pgp-substrate: | 0.001 |
Human Intestinal Absorption (HIA): | 0.004 | 20% Bioavailability (F20%): | 0.001 |
30% Bioavailability (F30%): | 0.003 |
Blood-Brain-Barrier Penetration (BBB): | 0.888 | Plasma Protein Binding (PPB): | 64.05% |
Volume Distribution (VD): | 0.344 | Fu: | 37.86% |
CYP1A2-inhibitor: | 0.077 | CYP1A2-substrate: | 0.455 |
CYP2C19-inhibitor: | 0.057 | CYP2C19-substrate: | 0.429 |
CYP2C9-inhibitor: | 0.088 | CYP2C9-substrate: | 0.103 |
CYP2D6-inhibitor: | 0.03 | CYP2D6-substrate: | 0.096 |
CYP3A4-inhibitor: | 0.045 | CYP3A4-substrate: | 0.107 |
Clearance (CL): | 0.762 | Half-life (T1/2): | 0.548 |
hERG Blockers: | 0.004 | Human Hepatotoxicity (H-HT): | 0.618 |
Drug-inuced Liver Injury (DILI): | 0.023 | AMES Toxicity: | 0.013 |
Rat Oral Acute Toxicity: | 0.053 | Maximum Recommended Daily Dose: | 0.102 |
Skin Sensitization: | 0.047 | Carcinogencity: | 0.412 |
Eye Corrosion: | 0.965 | Eye Irritation: | 0.979 |
Respiratory Toxicity: | 0.73 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC002923 | 0.258 | D05HXX | 0.271 | ||||
ENC003162 | 0.257 | D0J0ZS | 0.255 | ||||
ENC001278 | 0.256 | D04URO | 0.246 | ||||
ENC000592 | 0.241 | D0DZ3X | 0.233 | ||||
ENC003143 | 0.235 | D03QIP | 0.233 | ||||
ENC003725 | 0.235 | D0B4RU | 0.218 | ||||
ENC003050 | 0.226 | D00VZZ | 0.218 | ||||
ENC001071 | 0.225 | D07QKN | 0.212 | ||||
ENC005521 | 0.224 | D0Z1XD | 0.211 | ||||
ENC004661 | 0.224 | D0CK3G | 0.208 |